Adiponectin and adaptive immunity: linking the bridge from obesity to atherogenesis
Contributors
Steffens, Sabine; Mach, FrançoisPublished in
Circulation research, vol. 102, no. 2, p. 140-142Publication date
2008Keywords
- Adiponectin/immunology/physiology
- Adipose Tissue, White/immunology/pathology/secretion
- Atherosclerosis/etiology
- Cytokines/physiology
- Humans
- Immunity
- Inflammation/complications/etiology
- Obesity/complications/immunology/pathology
Note
Comment on: Okamoto Y, Folco EJ, Minami M, Wara AK, Feinberg MW, Sukhova GK, Colvin RA, Kihara S, Funahashi T, Luster AD, Libby P. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res. 2008 Feb 1;102(2):218-25UNIGE affiliation entities
Citation (ISO format)
STEFFENS, Sabine, MACH, François. Adiponectin and adaptive immunity: linking the bridge from obesity to atherogenesis. In: Circulation research, 2008, vol. 102, n° 2, p. 140–142. doi: 10.1161/CIRCRESAHA.107.170274
Main files (1)
Article (Accepted version)
Identifiers
- PID : unige:2142
- DOI : 10.1161/CIRCRESAHA.107.170274
- PMID : 18239140
